Our Science – St. Croix Website
Brad St. Croix, Ph.D.
Selected Publications |
 |
| 1)
Stránecký V, Hoischen A, Hartmannová H, Zaki MS, Chaudhary A, Zudaire E, Nosková L, Barešová V. Mutations in ANTXR1 Cause GAPO Syndrome. Am. J. Hum. Genet. [Epub ahead of print], 2013. [Journal] |
|
| 2)
Chaudhary A, St Croix B. Selective blockade of tumor angiogenesis. Cell Cycle. 11: 2253-9, 2012. [Journal] |
|
| 3)
Chaudhary A, Hilton MB, Seaman S, Haines DC, Stevenson S, Lemotte PK, Tschantz WR, Zhang XM, Saha S, Fleming T, St Croix B. TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types. Cancer Cell. 21: 212-26, 2012. [Journal] |
|
| 4)
Langenkamp E, Zwiers PJ, Moorlag HE, Leenders WP, St Croix B, Molema G. Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296. Anticancer Drugs. 23: 161-72, 2012. [Journal] |
|
| 5)
Meehan B, Appu S, St Croix B, Rak-Poznanska K, Klotz L, Rak J. Age-related properties of the tumour vasculature in renal cell carcinoma. BJU Int. 107: 416-24, 2011. [Journal] |
|
| 6)
Cullen M, Elzarrad MK, Seaman S, Zudaire E, Stevens J, Yang MY, Li X, Chaudhary A, Xu L, Hilton MB, Logsdon D, Hsiao E, Stein EV, Cuttitta F, Haines DC, Nagashima K, Tessarollo L, St Croix B. GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier. Proc. Natl. Acad. Sci. U.S.A. 108: 5759-64, 2011. [Journal] |
|
| 7)
Yang MY, Chaudhary A, Seaman S, Dunty J, Stevens J, Elzarrad MK, Frankel AE, St Croix B. The cell surface structure of tumor endothelial marker 8 (TEM8) is regulated by the actin cytoskeleton. Biochim. Biophys. Acta. 1813: 39-49, 2011. [Journal] |
|
| 8)
Cullen M, Seaman S, Chaudhary A, Yang MY, Hilton MB, Logsdon D, Haines DC, Tessarollo L, St Croix B. Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res. 69: 6021-6, 2009. [Journal] |
|
| 9)
Dang DT, Chun SY, Burkitt K, Abe M, Chen S, Havre P, Mabjeesh NJ, Heath EI, Vogelzang NJ, Cruz-Correa M, Blayney DW, Ensminger WD, St Croix B, Dang NH, Dang LH. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res. 68: 1872-80, 2008. [Journal] |
|
| 10)
Klement H, St Croix B, Milsom C, May L, Guo Q, Yu JL, Klement P, Rak J. Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy. Am. J. Pathol. 171: 1342-51, 2007. [Journal] |
|
| Click Here to View Expanded Bibliography. |
This page was last updated on 4/30/2013.
